These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 18258688)
1. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Rao AK; Ziegler YS; McLeod IX; Yates JR; Nardulli AM Mol Endocrinol; 2008 May; 22(5):1113-24. PubMed ID: 18258688 [TBL] [Abstract][Full Text] [Related]
2. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005 [TBL] [Abstract][Full Text] [Related]
3. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins. Higgins KJ; Liu S; Abdelrahim M; Vanderlaag K; Liu X; Porter W; Metz R; Safe S Mol Endocrinol; 2008 Feb; 22(2):388-402. PubMed ID: 18006642 [TBL] [Abstract][Full Text] [Related]
5. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation. Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399 [TBL] [Abstract][Full Text] [Related]
6. HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb. Ogba N; Chaplin LJ; Doughman YQ; Fujinaga K; Montano MM Cancer Res; 2008 Sep; 68(17):7015-24. PubMed ID: 18757415 [TBL] [Abstract][Full Text] [Related]
7. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692 [TBL] [Abstract][Full Text] [Related]
8. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247 [TBL] [Abstract][Full Text] [Related]
9. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. Rao AK; Ziegler YS; McLeod IX; Yates JR; Nardulli AM J Mol Endocrinol; 2009 Dec; 43(6):251-61. PubMed ID: 19620238 [TBL] [Abstract][Full Text] [Related]
10. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells. Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357 [TBL] [Abstract][Full Text] [Related]
11. The deoxyribonucleic acid repair protein flap endonuclease-1 modulates estrogen-responsive gene expression. Schultz-Norton JR; Walt KA; Ziegler YS; McLeod IX; Yates JR; Raetzman LT; Nardulli AM Mol Endocrinol; 2007 Jul; 21(7):1569-80. PubMed ID: 17488975 [TBL] [Abstract][Full Text] [Related]
12. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
14. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Guo P; Dong XY; Zhao KW; Sun X; Li Q; Dong JT Int J Cancer; 2010 Jan; 126(1):81-9. PubMed ID: 19569049 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638 [TBL] [Abstract][Full Text] [Related]
16. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells. Moy I; Todorović V; Dubash AD; Coon JS; Parker JB; Buranapramest M; Huang CC; Zhao H; Green KJ; Bulun SE Oncogene; 2015 Jan; 34(3):323-33. PubMed ID: 24413080 [TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells. Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971 [TBL] [Abstract][Full Text] [Related]
18. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Akaogi K; Nakajima Y; Ito I; Kawasaki S; Oie SH; Murayama A; Kimura K; Yanagisawa J Oncogene; 2009 Aug; 28(32):2894-902. PubMed ID: 19503094 [TBL] [Abstract][Full Text] [Related]
19. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595 [TBL] [Abstract][Full Text] [Related]
20. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells. De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]